In our April issue of Pharmaceutical Executive
FEATURES
Cover Story
Healthcare Businesswoman's Association Woman of the Year 2017
Kathleen Raven
For Bahija Jallal, this year's Healthcare Businesswomen's Association Woman of the Year, a passion for translational science has been the central guide in a career rise from cancer researcher to leading a big pharma biotech engine. |
Interview
Brexit Stage Left? Ireland Eyes Pharma Prize
Joseph Constance
A conversation with Tommy Fanning, head of biopharma at IDA Ireland, about the country's growth as a manufacturing powerhouse—and its bid to attract UK-based EMA post-Brexit. |
Interview
Advancing Rare Disease R&D: A Mission Update
Julian Upton
Pharm Exec talks to Christopher Austin, M.D., of the International Rare Diseases Research Consortium about the organizations's ongoing work to advance rare disease R&D. |
Drug Safety
Bracing for Drug Tracing Mandate
Greg Bylo
A pilot study affirms the value of a standards-based solution for prescription drug traceability—and the need to start now to meet compliance deadlines for the Drug Supply Chain Security Act. |
Drug Safety
The Lengthening Arm of Pharmacovigilance
Cheryl Key
Cheryl Key rounds up the expert debate the practice's rise up the life sciences agenda. |
ALSO IN THIS ISSUE
From the Editor: When Rare Becomes Common
Lisa Henderson
Two topics in Pharm Exec this month—rare disease research and women in healthcare leadership—share a “common” thread …Read more
A Faster, More Flexible, and Frugal FDA?
Jill Wechsler
Jill Wechsler outlines how the new FDA commissioner tasked with curbing regulation, speeding approvals—and collecting more fees to do it …Read more
Sales Force Effectiveness, Millennial Style
Julian Upton
A review of some of the sales strategy insights on offer at last month's eyeforpharma Barcelona event …Read more
|
| |
| WEBCASTS |
| Regenerative Medicine: Overcoming Obstacles to Reimbursement and Market Access |
| Patient Centricity: Turning Rhetoric into Reality |
Biologics Manufacturing – Is Your Company Ready?
|
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
|
From Big Data to Measurable Outcomes: Success with Value-Based Contracts
|
